Fluidigm Raises $5M

1/24/11

South San Francisco, CA-based Fluidigm, which makes instruments for measuring gene expression in single cells such as tumor cells, has raised $5 million in an offering of debt, options, and securities, according to a January 20 regulatory filing. The firm may have needed the funds to tide it over on its way to a planned initial public offering; the company restarted the paperwork for its IPO just last month, after abandoning plans to go public in 2008.

Wade Roush is a contributing editor at Xconomy. Follow @

By posting a comment, you agree to our terms and conditions.